SENSEARLY INC.
New Form D on file · 2025-03-11 · the record
Before you sell to, join or invest in SENSEARLY INC.
MentionFox check on SENSEARLY INC.: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/sensearly-inc-form-d-25000001
Check SENSEARLY INC. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about SENSEARLY INC.?
Based on the record MentionFox holds for this company. No flag is not a clearance.
SENSEARLY INC. filed a Form D with the Securities and Exchange Commission on 2025-03-11.
SENSEARLY INC. filed a Form D notice of an exempt securities offering with the SEC on March 11, 2025. The filing reports $1.70M sold. Its industry group is Biotechnology. It names Gangadhara Ganapati (Executive Officer, Director), G. Subramanian (Executive Officer, Director), Anita Kohli (Director) (SEC Form D, March 11, 2025).
Is this your company?
Sell to companies like SENSEARLY INC? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-03-11 · the record
Pitching, partnering or investing alongside them? See who really runs and owns SENSEARLY INC.
Free to see. No signup.
More on the people and the money behind SENSEARLY INC., from the filings we hold.
Biotechnology raises by companies based in California, filed in March 2025, largest first.
Get an email when SENSEARLY INC. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when SENSEARLY INC. raises, hires or launches. No email unless you switch it on.
Watch SENSEARLY INC. →Get the full cited report on SENSEARLY INC.
What the filing shows about SENSEARLY INC.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on SENSEARLY INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives SENSEARLY INC.'s address as 2671 Marshall Drive, Palo Alto, CA 94303.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
SENSEARLY INC. is a registered filer with the SEC (CIK 2059674) and has filed since 2025-03-11. 1 filing is on record, the latest on 2025-03-11.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
SENSEARLY INC.'s Form D of 2025-03-11 names Gangadhara Ganapati, G. Subramanian, Anita Kohli and 1 more as its officers, directors or promoters.
Its new offerings report $1.70M sold across 1 offering, as its own filings state.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
Gangadhara Ganapati is named as Executive Officer and Director on the Form D that SENSEARLY INC. filed with the SEC on 11 March 2025, one of 4 people that filing names.
G. Subramanian is named as Executive Officer and Director on the Form D that SENSEARLY INC. filed with the SEC on 11 March 2025, one of 4 people that filing names.
Anita Kohli is named as Director on the Form D that SENSEARLY INC. filed with the SEC on 11 March 2025, one of 4 people that filing names.
Tushar Chandra is named as Director on the Form D that SENSEARLY INC. filed with the SEC on 11 March 2025, one of 4 people that filing names.
4 people named on the filing — 2 holding an executive role and 2 as directors only.
Named as of the 2025-03-11 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about SENSEARLY INC.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on SENSEARLY INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on SENSEARLY INC. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist SENSEARLY INC.You get an alert in MentionFox the next time this company shows up.
If you're behind SENSEARLY INC.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for SENSEARLY INC.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in San Francisco Bay Area
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

https://mentionfox.com/funding/sensearly-inc-form-d-25000001